Alliance launches with 26 founding companies to develop a national strategy for U.S. biotechnology leadershipBOCA RATON, Fla., May 13, 2026 ...

PDS Biotechnology (NASDAQ:PDSB) reported a smaller first-quarter loss and highlighted changes to its late-stage head and neck ...

(Michael on for Roanna Ruiz), Leerink Partners: "what would constitute a clear signal as a green light to initiate Phase III in 2027?"; President, CEO & Director De Backer: "it's going to really be ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Automation, AI, and screening technologies are already transforming reproductive medicine. The tools may be accurate, but ...

Focused on immunology-based therapies for infectious diseases, this biotech company reported a notable insider sale in recent ...

Is VIR a good stock to buy? We came across a bullish thesis on Vir Biotechnology, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on VIR. Vir Biotechnology, ...

PennVet Study to Evaluate GMP-Grade Metformin Eye Drops in a Canine Model Supporting Human and Veterinary Development Pathways ...

Net loss for Q1 2026 improved to $7.3 million compared to $8.5 million in the prior year, primarily due to reduced clinical ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

Biotechnology stocks are among the most high-risk, high-reward stocks in the market. Many biotech companies are working to ...

College of Agriculture, Biotechnology & Natural Resources honors achievement in academics, leadership and research at 2026 ...